Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Aries Science & Technology and Enveric Biosciences Announce Licensing Agreement
Tuesday, July 16, 2024Enveric Biosciences a biotechnology company dedicated to the development of novel neuroplastogens for the treatment of neuropsychiatric disorders and Aries Science Technology
GC Cell and Checkpoint Therapeutics Advance Collaborative Cancer Research
Tuesday, July 16, 2024GC Cell and Checkpoint Therapeutics have announced a collaboration to explore the combined therapeutic potential of cosibelimab Checkpoints antiPDL antibody with dual mechanism
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
Monday, July 15, 2024Eton Pharmaceuticals Inc an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases today announced the Companys New Drug
Ipsen and Foreseen Biotechnology Announce Exclusive Worldwide License Agreement for Antibody-Drug Conjugate with First-in-Class Potential
Friday, July 12, 2024Ipsen and Foreseen Biotechnology today announced the signing of an exclusive worldwide license agreement for FS a potentially firstinclass antibodydrug
Pfizer Advances Development of Once-Daily Formulation of Oral GLP-1 Receptor Agonist Danuglipron
Friday, July 12, 2024Pfizer Inc today announced that based on results from the ongoing pharmacokinetic study the company has selected its preferred oncedaily modified release formulation for danuglipron
Evotec and Pfizer Collaborate to Advance Drug Discovery in France
Thursday, July 11, 2024Evotec SE today announced it has entered into a multiyear master research collaboration and option and license agreement with Pfizer Under the agreement Evotec and Pfizer will initially focus on early discovery research for metabolic
Oxford Drug Design Announces Initial in Vivo Validation of Novel Oncology Therapeutic Mechanism
Thursday, July 11, 2024Oxford Drug Design the Oxfordbased AI drug discovery company applying its pioneering AI platform to develop novel molecules for use in cancer treatments has successfully completed the first in vivo validation
FDA Approved PDE4 Inhibitor Roflumilast for Atopic Dermatitis
Thursday, July 11, 2024On July th the US FDA approved Arcutis Biotherapeutics ZORYVE roflumilast for treating atopic dermatitis AD the most common type of eczema affecting millions
Gain Therapeutics Announces the Completion of Dosing in the Multiple Ascending Dose (MAD) of the Phase 1 Study of GT-02287, a Novel Small Molecule Therapy for Parkinson’s Disease
Wednesday, July 10, 2024Gain Therapeutics Inc a clinicalstage biotechnology company leading the discovery and development of the next generation of allosteric small
Immix Biopharma Doses 1st Patient in U.S. AL Amyloidosis Trial with CAR-T NXC-201
Tuesday, July 09, 2024Immix Biopharma Inc a clinicalstage biopharmaceutical company trailblazing cell therapies in AL Amyloidosis and autoimmune disease today announced that the st patient has been dosed at MSKCC in its US NEXICART
